🇺🇸 FDA
Patent

US 10881684

Artificial invaplex formulated with deacylated lipopolysaccharide

granted A61KA61K2039/543A61K2039/55572

Quick answer

US patent 10881684 (Artificial invaplex formulated with deacylated lipopolysaccharide) held by United States Government as represented by the Secretary of the Army expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Secretary of the Army
Grant date
Tue Jan 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/543, A61K2039/55572, A61K2039/70, A61K31/739